The Role of Contrast Enhanced Ultrasound in Appendicitis
Launched by CHILDREN'S MERCY HOSPITAL KANSAS CITY · Sep 25, 2018
Trial Information
Current as of June 05, 2025
Completed
Keywords
ClinConnect Summary
This will be a single-center, non-randomized trial that will add to our institution's current diagnostic algorithm using Contrast Enhanced Ultra Sound (CEUS) in subjects who are clinically suspicious for acute appendicitis.
For those who consent to study participation, we propose obtaining a CEUS after the initial gray-scale ultrasound. Once the initial ultrasound is complete, the contrast Lumason® (sulfur hexafluoride lipid type-A microspheres) will be administered through an already existing IV catheter and an abdominal scan will be completed. The patient will then continue with standard...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Present to Children's Mercy Adele Hall campus with a clinical concern for acute appendicitis
- • Age 8 through 17 years
- • seen between Institutional Review Board (IRB) approval date and 12/31/2019
- • Seen Monday- Friday between the hours of 9:00 a.m. and 4:00 pm
- • Has had an IV catheter placed as part of their standard of care
- Exclusion Criteria:
- • Known cardiac abnormality
- • Pulmonary hypertension
- • Known sensitivity to sulfur hexafluoride, polyethylene glycol 4000, distearoylphosphatidylcholine (DSPC), dipalmitoylphosphatidylglycerol sodium (DPPG-Na), or palmitic acid
- • Does not had an IV catheter placed
- • Unable to roll over
- • Unable to assent
- • Pregnant
- • Lactating
- • Received an ultrasound image from a referring facility
About Children's Mercy Hospital Kansas City
Children's Mercy Hospital Kansas City is a renowned pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative research and clinical trials. As a leading sponsor of clinical trials, the hospital focuses on developing and testing new treatments and therapies that address a wide range of pediatric conditions. With a commitment to excellence in patient care and a collaborative approach to research, Children's Mercy is at the forefront of pediatric medicine, striving to improve outcomes and enhance the quality of life for children and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Missouri, United States
Patients applied
Trial Officials
Tolulope Oyetunji, MD
Principal Investigator
Children's Mercy Hospital Kansas City
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials